Inherited Retinal Disease Market Report: Trends, Forecast and Competitive Analysis to 2030

Inherited Retinal Disease Market Report: Trends, Forecast and Competitive Analysis to 2030

Inherited Retinal Disease Trends and Forecast

The future of the global inherited retinal disease (IRD) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Inherited Retinal Disease by Segment

The study includes a forecast for the global inherited retinal disease by type, disease type, end use, distribution channel, and region.

Inherited Retinal Disease Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Diagnosis
• Therapy

Inherited Retinal Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Retinitis Pigmentosa
• Stargardt'S Disease
• Achromatopsia
• Cone-Rod Dystrophy
• Choroideremia
• Leber Congenital Amaurosis
• Macular Edema
• Others

Inherited Retinal Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Home Healthcare
• Others

Inherited Retinal Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Retail Sales
• Direct Tender

Inherited Retinal Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Inherited Retinal Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inherited retinal disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inherited retinal disease companies profiled in this report include-

• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos

Inherited Retinal Disease Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Within this market, hospital will remain the largest segment due to the presence of resources and expertise to provide a wide range of services for patients with inherited retinal diseases, including diagnosis, treatment, and rehabilitation.

North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Features of the Global Inherited Retinal Disease Market

Market Size Estimates: Inherited retinal disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inherited retinal disease market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).

Regional Analysis: Inherited retinal disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the inherited retinal disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inherited retinal disease market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the inherited retinal disease market size?

Answer: The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for inherited retinal disease market?

Answer: The global inherited retinal disease market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the inherited retinal disease market?

Answer: The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

Q4. What are the major segments for inherited retinal disease market?

Answer: The future of the inherited retinal disease market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.

Q5. Who are the key inherited retinal disease market companies?

Answer: Some of the key inherited retinal disease companies are as follows:

• Spark Therapeutics
• Novartis
• Okuvision
• Nidek
• Invitae Corporation
• Zeiss
• Optos

Q6. Which inherited retinal disease market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Q7. In inherited retinal disease market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the inherited retinal disease market by type (diagnosis and therapy), disease type (retinitis pigmentosa, stargardt's disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (retail sales and direct tender), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.